AI and the pharmaceutical market are an ideal match ... Two primary hazards, that can both discount the benefits of using AI as well as derail authentic innovation, are model bias and automation ...

Andrew Pierce, senior executive at French biotech Owkin, on how artificial intelligence can make the drug development process more efficient.

Additional benefits to leveraging AI include: Generative AI is revolutionising content automation for all industries, but has the potential to significantly disrupt the way pharma companies have ...

The pharmaceutical industry is on the verge of a significant transformation due to the emergence of artificial intelligence ...

For large pharmaceutical companies, the benefits of AI tools in drug discovery often outweigh the IP risks, but those risks must still be managed strategically. Adopting an AI policy and framework ...

Laura Florence, chief creative officer of Rise & Run, an IPG Health Company. “In 2025, AI will impact content production in pharma marketing, shifting from cautious experimentation to integrated ...

Survey finds AI to enhance productivity and cut costs in the next 12 months AI is poised to significantly lower pharmaceutical R&D costs through efficient drug discovery, optimised clinical trials, ...

A total of 101 responses from biotech and pharmaceutical professionals across ... in addition to the required investment and approaches, the benefits of AI and digital tools in R&D can be realised ...

The company revealed plans to increase the usage of AI in pharma at JP Morgan’s healthcare conference in San Francisco. Over the past two years, the life sciences industry has seemingly fully embraced ...

The sector will continue to embrace artificial intelligence, machine learning, and blockchain technology to enhance efficiencies and accelerate pharmaceutical research and development. These ...

A global AI in pharma and biotech industry valuation of US$ 1.8 billion was estimated for 2023. The market will reach US$ 13.1 billion by 2034, with a CAGR of 18.8% between 2024 and 2034. Healthcare ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...